Seelos Therapeutics, Inc.

TOCQUEVILLE ASSET MANAGEMENT L.P.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

48,000

Value ($000)

57

Weight

0.0%

2020 Q1 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	57	0.0%	48,000	6/30/2023
2023 Q1	5/10/2023	40	0.0%	58,000	3/31/2023
2022 Q4	2/9/2023	37	0.0%	55,000	12/31/2022
2022 Q2	8/12/2022	81	0.0%	118,400	6/30/2022
2022 Q1	5/16/2022	99	0.0%	118,400	3/31/2022
2021 Q4	2/14/2022	193	0.0%	118,400	12/31/2021
2021 Q3	11/15/2021	299	0.0%	123,900	9/30/2021
2021 Q2	8/16/2021	419	0.0%	158,900	6/30/2021
2021 Q1	5/17/2021	992	0.0%	198,800	3/31/2021
2020 Q4	2/16/2021	166	0.0%	105,000	12/31/2020
2020 Q3	11/16/2020	37	0.0%	40,000	9/30/2020
2020 Q2	8/12/2020	183	0.0%	181,500	6/30/2020
2020 Q1	5/15/2020	94	0.0%	191,000	3/31/2020